The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 30, 2016

Filed:

Feb. 27, 2014
Applicant:

National Cancer Center, Chuo-ku, Tokyo, JP;

Inventors:

Yasuhiro Matsumura, Kashiwa, JP;

Masahiro Yasunaga, Kashiwa, JP;

Yohei Hisata, Kashiwa, JP;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G01N 33/86 (2006.01); C07K 16/18 (2006.01); A61K 47/48 (2006.01); C07K 16/36 (2006.01);
U.S. Cl.
CPC ...
G01N 33/86 (2013.01); A61K 47/48538 (2013.01); C07K 16/18 (2013.01); C07K 16/36 (2013.01); C07K 2317/33 (2013.01); C07K 2317/34 (2013.01); G01N 2333/75 (2013.01); G01N 2800/226 (2013.01);
Abstract

With the intention of providing an antibody which does not bind to fibrinogen and which has a high affinity for and a high specificity to insoluble fibrin, it is found that a site comprising the amino acids at positions 231 to 246 of the fibrinogen Bβ chain and a site comprising the amino acids at positions 232 to 246 of the fibrinogen γ chain are bound to each other in a fibrinogen molecule. Further, it is shown that when fibrinogen is converted to insoluble fibrin, the binding is released, and these sites are exposed. It is also found that antibodies obtained by immunization with these sites do not bind to fibrinogen and have high affinity for and high specificity to insoluble fibrin.


Find Patent Forward Citations

Loading…